Bicara Therapeutics Inc (BCAX) PT Lowered to $41 at H.C. Wainwright
Tweet Send to a Friend
H.C. Wainwright analyst Robert Burns lowered the price target on Bicara Therapeutics Inc (NASDAQ: BCAX) to $41.00 (from $44.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
